The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples